Details of the Drug

General Information of Drug (ID: DMLDJGX)

Drug Name

PF-06412562

Indication

Disease Entry	ICD 11	Status	REF
Cognitive impairment	6D71	Phase 1	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT02418819) A Study To Examine Safety, Pharmacokinetics, And Pharmacodynamic Of Pf 06412562 In Schizophrenic Patients. U.S. National Institutes of Health.